Literature DB >> 15694134

Canine and feline models of human inherited muscle diseases.

G Diane Shelton1, Eva Engvall.   

Abstract

Animal models are of immense importance for studying mechanisms of disease and testing new therapies, and rodents have been used extensively in the field of neuromuscular disorders. Mice and rats can be genetically manipulated to over-express or not express genes that are important to muscle function, and these animals can be available in large numbers for analysis. Other species, such as cats and dogs, cannot be manipulated in the same ways or be used in large numbers, but they have spontaneously occurring muscle diseases with clinical presentations more closely resembling those of the human disorders. Therefore, cats and dogs may become valuable as intermediate disease models. This review focuses on canine and feline models of human inherited muscle diseases with comparisons to rodent models and an emphasis on the muscular dystrophies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15694134     DOI: 10.1016/j.nmd.2004.10.019

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  36 in total

1.  Whole body skeletal muscle transduction in neonatal dogs with AAV-9.

Authors:  Yongping Yue; Jin-Hong Shin; Dongsheng Duan
Journal:  Methods Mol Biol       Date:  2011

Review 2.  The congenital muscular dystrophies: recent advances and molecular insights.

Authors:  Jerry R Mendell; Daniel R Boué; Paul T Martin
Journal:  Pediatr Dev Pathol       Date:  2006 Nov-Dec

3.  Intra-amniotic rAAV-mediated microdystrophin gene transfer improves canine X-linked muscular dystrophy and may induce immune tolerance.

Authors:  Hiromi Hayashita-Kinoh; Naoko Yugeta; Hironori Okada; Yuko Nitahara-Kasahara; Tomoko Chiyo; Takashi Okada; Shin'ichi Takeda
Journal:  Mol Ther       Date:  2015-01-14       Impact factor: 11.454

4.  Age-matched comparison reveals early electrocardiography and echocardiography changes in dystrophin-deficient dogs.

Authors:  Deborah M Fine; Jin-Hong Shin; Yongping Yue; Dietrich Volkmann; Stacey B Leach; Bruce F Smith; Mark McIntosh; Dongsheng Duan
Journal:  Neuromuscul Disord       Date:  2011-05-13       Impact factor: 4.296

5.  Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs.

Authors:  Karl Rouger; Thibaut Larcher; Laurence Dubreil; Jack-Yves Deschamps; Caroline Le Guiner; Gregory Jouvion; Bruno Delorme; Blandine Lieubeau; Marine Carlus; Benoît Fornasari; Marine Theret; Priscilla Orlando; Mireille Ledevin; Céline Zuber; Isabelle Leroux; Stéphane Deleau; Lydie Guigand; Isabelle Testault; Elisabeth Le Rumeur; Marc Fiszman; Yan Chérel
Journal:  Am J Pathol       Date:  2011-09-13       Impact factor: 4.307

6.  A simplified immune suppression scheme leads to persistent micro-dystrophin expression in Duchenne muscular dystrophy dogs.

Authors:  Jin-Hong Shin; Yongping Yue; Arun Srivastava; Bruce Smith; Yi Lai; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2011-12-14       Impact factor: 5.695

Review 7.  Animal models for genetic neuromuscular diseases.

Authors:  Mariz Vainzof; Danielle Ayub-Guerrieri; Paula C G Onofre; Poliana C M Martins; Vanessa F Lopes; Dinorah Zilberztajn; Lucas S Maia; Karen Sell; Lydia U Yamamoto
Journal:  J Mol Neurosci       Date:  2008-01-18       Impact factor: 3.444

8.  Respiratory dysfunction in unsedated dogs with golden retriever muscular dystrophy.

Authors:  Justin C DeVanna; Joe N Kornegay; Daniel J Bogan; Janet R Bogan; Jennifer L Dow; Eleanor C Hawkins
Journal:  Neuromuscul Disord       Date:  2013-10-24       Impact factor: 4.296

9.  Analysis of cat oocyte activation methods for the generation of feline disease models by nuclear transfer.

Authors:  Chunmin Wang; William F Swanson; Jason R Herrick; Kiho Lee; Zoltan Machaty
Journal:  Reprod Biol Endocrinol       Date:  2009-12-11       Impact factor: 5.211

10.  A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping.

Authors:  Gemma L Walmsley; Virginia Arechavala-Gomeza; Marta Fernandez-Fuente; Margaret M Burke; Nicole Nagel; Angela Holder; Rachael Stanley; Kate Chandler; Stanley L Marks; Francesco Muntoni; G Diane Shelton; Richard J Piercy
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.